These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11128638)
1. 6-Hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors. Lee YS; Lee YS; Lee JY; Kim SN; Lee CK; Park H Bioorg Med Chem Lett; 2000 Dec; 10(23):2625-7. PubMed ID: 11128638 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease. Min BS; Jung HJ; Lee JS; Kim YH; Bok SH; Ma CM; Nakamura N; Hattori M; Bae K Planta Med; 1999 May; 65(4):374-5. PubMed ID: 10364847 [TBL] [Abstract][Full Text] [Related]
3. New anti-HIV derivatives: synthesis and antiviral evaluation. De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity. Wei Y; Ma CM; Hattori M Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591 [TBL] [Abstract][Full Text] [Related]
5. Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Chen X; Kempf DJ; Sham HL; Green BE; Molla A; Korneyeva M; Vasavanonda S; Wideburg NE; Saldivar A; Marsh KC; McDonald E; Norbeck DW Bioorg Med Chem Lett; 1998 Dec; 8(24):3531-6. PubMed ID: 9934466 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Sham HL; Betebenner DA; Herrin T; Kumar G; Saldivar A; Vasavanonda S; Molla A; Kempf DJ; Plattner JJ; Norbeck DW Bioorg Med Chem Lett; 2001 Jun; 11(11):1351-3. PubMed ID: 11378352 [TBL] [Abstract][Full Text] [Related]
9. Tricyclic ureas: a new class of HIV-1 protease inhibitors. Han W; Pelletier JC; Hodge CN Bioorg Med Chem Lett; 1998 Dec; 8(24):3615-20. PubMed ID: 9934481 [TBL] [Abstract][Full Text] [Related]
10. From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors. Bhhatarai B; Garg R Bioorg Med Chem; 2005 Jun; 13(12):4078-84. PubMed ID: 15911321 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease. Sheha MM; Mahfouz NM; Hassan HY; Youssef AF; Mimoto T; Kiso Y Eur J Med Chem; 2000 Oct; 35(10):887-94. PubMed ID: 11121614 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel conformationally restricted HIV protease inhibitors. Salituro FG; Baker CT; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Porter MD; Schairer WC; Tung RD Bioorg Med Chem Lett; 1998 Dec; 8(24):3637-42. PubMed ID: 9934485 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of triterpene-azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease. Ma CM; Nakamura N; Hattori M; Kawahata T; Otake T Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):877-80. PubMed ID: 12045355 [TBL] [Abstract][Full Text] [Related]
14. Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease. Kazmierski WM; Furfine E; Spaltenstein A; Wright LL Bioorg Med Chem Lett; 2002 Dec; 12(23):3431-3. PubMed ID: 12419377 [TBL] [Abstract][Full Text] [Related]
15. Discovery and clinical development of HIV-1 protease inhibitors. Huff JR; Kahn J Adv Protein Chem; 2001; 56():213-51. PubMed ID: 11329855 [No Abstract] [Full Text] [Related]